Technology Development Platform, Institut Pasteur Korea, 16, Daewangpangyo-ro 712beon-gil, Bundang-gu, Seongnam-si, 13488, Republic of Korea.
Division of Bio-Medical Science & Technology, Korea University of Science and Technology, 217 Gajeong-ro Yuseong-gu, Daejeon, Republic of Korea.
Sci Rep. 2024 Sep 30;14(1):22685. doi: 10.1038/s41598-024-73130-3.
In vivo fluorescent imaging represents a potent means for real-time probe quantification, facilitating insights into disease pathophysiology and therapeutic responses. Nonetheless, accurate signal quantification remains challenging due to inherent factors like light scattering and tissue absorption. Existing imaging systems, though sophisticated, often entail high costs and are typically restricted to well-funded laboratory settings. This study introduces BrightMice, an innovative in vivo fluorescent imaging system that harnesses 3D printing and consumer-grade digital cameras. Tailored for various fluorophores such as EYFP and E2-crimson, the system showcases both adaptability and effectiveness in detecting in vivo fluorescent signals in several reporter mouse strains. Comparative analyses against commercial instruments confirm BrightMice's sensitivity and underscore its potential to democratize in vivo fluorescence imaging. By providing a cost-effective and accessible solution, BrightMice stands to benefit diverse research environments.
体内荧光成像是一种实时探针定量的有力手段,可以深入了解疾病的病理生理学和治疗反应。然而,由于光散射和组织吸收等固有因素,准确的信号定量仍然具有挑战性。现有的成像系统虽然复杂,但往往成本高昂,通常仅限于资金充足的实验室环境。本研究介绍了 BrightMice,这是一种创新的体内荧光成像系统,利用 3D 打印和消费级数码相机。该系统针对 EYFP 和 E2-crimson 等各种荧光染料进行了定制,在几种报告小鼠品系中展示了在体内荧光信号检测方面的适应性和有效性。与商业仪器的对比分析证实了 BrightMice 的灵敏度,并强调了其在体内荧光成像民主化方面的潜力。通过提供经济实惠和易于使用的解决方案,BrightMice 将使各种研究环境受益。